Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Once-Daily Raltegravir and Etravirine in HIV
NCT01121809Phase 4Completed
- Sponsor
- Hospital Universitario Virgen del Rocío
- Start
- Apr 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir, etravirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Hospital Universitario Virgen del Rocío. Started Apr 2010; status: completed.
02
Drugs
raltegraviretravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01121809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01121809.